Labshake search

1601 - 1650 of 10000+ citations for Anti Epidermis type lipoxygenase 12 since 2020

• Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies

  S. Jordan Kerns, et al., bioRxiv - Cancer Biology 2021

  Quote: ... and anti-human CD69 APC (BioLegend).
• Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

  Daniel Neumeier, et al., bioRxiv - Immunology 2021

  Quote: ... anti-IgK-Brilliant Violet421 (BioLegend, 409511) and OVA-AlexaFluor647 (0.86 mg/ml ...
• Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination

  Alice Cho, et al., bioRxiv - Immunology 2021

  Quote: ... anti-CD71- PerCP-Cy5.5 (Biolegend, 334114), anti- IgG-PECF594 (BD biosciences ...
• The In Vivo Source of Type I and Type III IFNs is Pathogen Dependent

  Marvin J. Sandoval, et al., bioRxiv - Immunology 2021

  Quote: ... anti-mouse CD3-APC Cy7 (BioLegend), anti-mouse CD11c-APC (eBioscience) ...
• The In Vivo Source of Type I and Type III IFNs is Pathogen Dependent

  Marvin J. Sandoval, et al., bioRxiv - Immunology 2021

  Quote: ... anti-mouse F4/80-APC (BioLegend), anti-mouse CD11c-PerCPCy5.5 (BioLegend) ...
• Platelets are dispensable for the ability of CD8+ T cells to accumulate, patrol, kill and reside in the liver

  James H. O’Connor, et al., bioRxiv - Immunology 2021

  Quote: ... and anti-CD8 (clone 53.67- Biolegend). Cultures were then analysed using Amnis ImageStream®X (Merck Millipore).
• Platelets are dispensable for the ability of CD8+ T cells to accumulate, patrol, kill and reside in the liver

  James H. O’Connor, et al., bioRxiv - Immunology 2021

  Quote: ... anti-CD3 (clone 17.A2- Biolegend). Samples were then resuspended in FACs buffer with viability dye (7-AAD ...
• A transmissible γδ intraepithelial lymphocyte hyperproliferative phenotype is associated with the intestinal microbiota and confers protection against acute infection

  Luo Jia, et al., bioRxiv - Immunology 2021

  Quote: ... and anti-Vγ1 (clone 2.11, BioLegend) or a Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit (Invitrogen) ...
• Cyclophilin A regulates protein phase separation and mitigates haematopoietic stem cell aging

  Laure Maneix, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD150 (clone TC15-12F12.2, BioLegend), anti-CD127 (clone SB/199 ...
• Cyclophilin A regulates protein phase separation and mitigates haematopoietic stem cell aging

  Laure Maneix, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD127 (clone SB/199, BioLegend) and anti-CD45.1/2 (clones A20 and 104 ...
• Interleukin-11 is a Marker for Both Cancer- and Inflammation-Associated Fibroblasts that Contribute to Colorectal Cancer Progression

  Takashi Nishina, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-podoplanin (BioLegend, 127414, clone 8.1.1), anti-TER-119 (BioLegend ...
• Interleukin-11 is a Marker for Both Cancer- and Inflammation-Associated Fibroblasts that Contribute to Colorectal Cancer Progression

  Takashi Nishina, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-EpCAM (BioLegend, 118214, clone G8.8), anti-Thy1.2 (20-0903 ...
• Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger Cyclin K degradation

  Lu Lv, et al., bioRxiv - Biochemistry 2020

  Quote: ... anti-HA (BioLegend, 901533, 1:4,000), anti-RNA polymerase II subunit B1 (phospho CTD Ser-2 ...
• Assessment of CAR-T mediated and targeted cytotoxicity in 3D microfluidic TBNC co-culture models for combination therapy

  K. Paterson, et al., bioRxiv - Bioengineering 2021

  Quote: ... anti-PD-L1 antibodies (329701, Biolegend) were injected into devices after a 1:100 dilution in culture media ...
• The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28

  Yannick D. Muller, et al., bioRxiv - Bioengineering 2020

  Quote: ... anti-CD28 APC (clone 28.2, Biolegend), CD8 APC-Cy7 (clone SK1 Biolegend) ...
• The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28

  Yannick D. Muller, et al., bioRxiv - Bioengineering 2020

  Quote: ... anti-CD71 FITC (clone CY1G4, Biolegend), anti Myc FITC or APC (clone 9B11 ...
• Antibody-based delivery of Interleukin-9 to neovascular structures: therapeutic evaluation in cancer and arthritis

  Baptiste Gouyou, et al., bioRxiv - Bioengineering 2020

  Quote: ... or rat anti-mCD335 (NKp46) (Biolegend). Goat anti-rat IgG Alexa FluorTM 488 (Invitrogen ...
• G-baToN: a versatile reporter system for cancer cell-stromal cell interactions

  Rui Tang, et al., bioRxiv - Bioengineering 2020

  Quote: ... or anti-Sirpa-AF467 (Biolegend, 144027) (for cardiomyocyte ...
• The solute carrier MFSD1 decreases β1 integrin’s activation status and thus tumor metastasis

  Marko Roblek, et al., bioRxiv - Cancer Biology 2021

  Quote: ... anti-LAMP1 (clone 1D4B, BioLegend, #121601), anti-cleaved caspase 3 (Cell Signaling Technology ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PE-Cy5 anti-mouse CD4 (BioLegend), PE-Cy7 anti-mouse CD169 (BioLegend) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PerCP-Cy5.5 anti-mouse CD45 (BioLegend), PerCp-eFluor711 anti-mouse CD80 (Invitrogen) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PE-Cy7 anti-mouse CD169 (BioLegend), APC anti-mouse FoxP3 (Invitrogen) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... incubation in anti-PE nanobeads (BioLegend) occurred ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PE-Dazzle594 anti-mouse CD25 (BioLegend), PE-Cy5 anti-mouse CD4 (BioLegend) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... incubation in anti-APC nanobeads (BioLegend) and sorting ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... BV711 anti-mouse Ly-6C (BioLegend), BV750 anti-mouse CD45R/B220 (BioLegend) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... BV650 anti-mouse F4/80 (BioLegend), BV650 anti-mouse MHC II (IA-IE ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... BV750 anti-mouse CD45R/B220 (BioLegend), BV785 anti-mouse CD11b (BioLegend) ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD36 (1:100; Biolegend #336203), anti-CD146 (1:200 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD45 (1:100; BioLegend #304005), anti-PDGFRβ (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD31 (1:100; BioLegend #303103), anti-CD45 (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD146 (1:100; BioLegend #342011), anti-FAP (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-PDGFRβ (1:100; BioLegend #323605), anti-PDGFRα (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-PDGFRα (1:100; BioLegend #323507) and anti-CD146 (1:100 ...
• Control of Neutrophil activation through Semaphorin 7A-Plexin C1 is essential for immune defense during pulmonary sepsis

  Tiago Granja, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD62L PerCP/Cy5.5 (BioLegend #104431) and rat anti-mouse activated GPIIb/IIIa PE (Emfret ...
• Control of Neutrophil activation through Semaphorin 7A-Plexin C1 is essential for immune defense during pulmonary sepsis

  Tiago Granja, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD66b PE/Cy7 (BioLegend #108416), anti-LFA1-PE (BioLegend #141006) ...
• Efferent Synaptic Transmission at the Vestibular Type II Hair Cell Synapse

  Zhou Yu, et al., bioRxiv - Neuroscience 2020

  Quote: ... mouse anti-TUJ1(1:250, BioLegend), rabbit anti-MyosinVIIa (1:250 ...
• Expression of extracellular Hsp90 is a molecular signature of T cell activation, providing a means to image and target T Cell activation in autoimmune disease

  Scott A. Scarneo, et al., bioRxiv - Pharmacology and Toxicology 2021

  Quote: ... 3:20,000 anti-CD28 (BioLegend 302913), and 1:10,000 (30 IU/mL ...
• In vitro characterization of engineered red blood cells as potent viral traps against HIV-1 and SARS-CoV-2

  Magnus A. G. Hoffmann, et al., bioRxiv - Bioengineering 2020

  Quote: ... FITC-conjugated anti-human CCR5 (BioLegend), PE-conjugated anti-human CXCR4 (Invitrogen) ...
• Heparan Sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE

  Miaomiao Li, et al., bioRxiv - Cell Biology 2021

  Quote: ... rat anti-mouse CD45-FITC (Biolegend), and rat anti-mouse CD11b-APC (Biolegend ...
• The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147-receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease

  Elisa Avolio, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD147 (BioLegend #306221, 1:100); anti-Transmembrane Serine Protease 2 (TMPRSS2 - Proteintech 14437-1-AP ...
• Physical and functional interactome atlas of human receptor tyrosine kinases

  Kari Salokas, et al., bioRxiv - Systems Biology 2021

  Quote: ... or mouse anti-HA.11 (BioLegend) primary antibodies and polyclonal goat anti-mouse HRP conjugated (GE Healthcare ...
• Multicohort Analysis of Publicly-available Monocyte Expression Data Identifies Gene Signatures to Accurately Monitor Subset-specific Changes in Human Diseases

  Francesco Vallania, et al., bioRxiv - Systems Biology 2020

  Quote: ... PE anti-GPR183 (clone SA313E4, Biolegend)at 1:20 ...
• Multicohort Analysis of Publicly-available Monocyte Expression Data Identifies Gene Signatures to Accurately Monitor Subset-specific Changes in Human Diseases

  Francesco Vallania, et al., bioRxiv - Systems Biology 2020

  Quote: ... PerCP/Cy5.5 anti-CD114 (cloneLMM741, Biolegend) at 1 ...
• A novel innate pathogen sensing strategy involving ubiquitination of bacterial surface proteins

  Shruti Apte, et al., bioRxiv - Microbiology 2021

  Quote: ... HRP tagged anti-mouse (Biolegend 405306), Anti-rabbit Alexa Fluor 488 (Invitrogen A27206) ...
• Sustained IL-15 response signature predicts RhCMV/SIV vaccine efficacy

  Fredrik Barrenäs, et al., bioRxiv - Genomics 2021

  Quote: ... anti-IFN-γ (B27: APC; BioLegend) and anti-CD69 (FN50 ...
• Endothelial expression of human APP leads to cerebral amyloid angiopathy in mice

  Yuriko Tachida, et al., bioRxiv - Neuroscience 2020

  Quote: ... anti-CD146 (rat, ME-9F1, BioLegend), anti-GAPDH (mouse ...
• Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells

  Judith Grau-Expósito, et al., bioRxiv - Microbiology 2021

  Quote: ... and anti-HLA-DR (BV421, BioLegend). For ACE2 detection ...
• Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells

  Judith Grau-Expósito, et al., bioRxiv - Microbiology 2021

  Quote: ... and anti-HLA-DR (BV421, BioLegend). For ACE2 detection ...
• Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells

  Judith Grau-Expósito, et al., bioRxiv - Microbiology 2021

  Quote: ... and anti-HLA-DR (BV421, BioLegend). Cells were subsequently fixed and permeabilized using the Cytofix/Cytoperm™ kit (BD Biosciences ...